0001235802-19-000129.txt : 20191015 0001235802-19-000129.hdr.sgml : 20191015 20191015162346 ACCESSION NUMBER: 0001235802-19-000129 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20191015 FILED AS OF DATE: 20191015 DATE AS OF CHANGE: 20191015 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Browne Sean E CENTRAL INDEX KEY: 0001790461 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-34951 FILM NUMBER: 191151187 MAIL ADDRESS: STREET 1: 664 CRUISER LANE CITY: BELGRADE STATE: MT ZIP: 59714 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Xtant Medical Holdings, Inc. CENTRAL INDEX KEY: 0001453593 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] IRS NUMBER: 205313323 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 664 CRUISER LANE CITY: BELGRADE STATE: MT ZIP: 59714 BUSINESS PHONE: 406-388-0480 MAIL ADDRESS: STREET 1: 664 CRUISER LANE CITY: BELGRADE STATE: MT ZIP: 59714 FORMER COMPANY: FORMER CONFORMED NAME: Bacterin International Holdings, Inc. DATE OF NAME CHANGE: 20100615 FORMER COMPANY: FORMER CONFORMED NAME: K KITZ INC DATE OF NAME CHANGE: 20090108 4 1 primary_doc.xml PRIMARY DOCUMENT X0306 4 2019-10-15 0 0001453593 Xtant Medical Holdings, Inc. XTNT 0001790461 Browne Sean E 664 CRUISER LANE BELGRADE MT 59714 0 1 0 0 President and CEO Common Stock, $0.000001 par value 2019-10-15 4 A 0 329044 0 A 329044 D Stock Option 2.7 2019-10-15 4 A 0 329044 0 A 2029-10-15 Common Stock 329044 329044 D These shares will vest and be issued with respect to 65,809 shares on each of October 15, 2020, October 15, 2021, October 15, 2022 and October 15, 2023 and with respect to 65,808 shares on October 15, 2024 pursuant to a restricted stock unit award granted under the Xtant Medical Holdings, Inc. 2018 Equity Incentive Plan, conditioned upon the reporting person remaining an employee of Xtant through the vesting date. This option vests with respect to 65,809 shares on each of October 15, 2020, October 15, 2021, October 15, 2022 and October 15, 2023 and with respect to 65,808 shares on October 15, 2024 pursuant to an option award granted under the Xtant Medical Holdings, Inc. 2018 Equity Incentive Plan, conditioned upon the reporting person remaining an employee of Xtant through the vesting date. /s/ Sean E. Browne 2019-10-15